BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10533889)

  • 1. Mycophenolate mofetil in IBD patients.
    Radford-Smith GL; Taylor P; Florin TH
    Lancet; 1999 Oct; 354(9187):1386-7. PubMed ID: 10533889
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine, tacrolimus, and mycophenolate mofetil in the treatment of inflammatory bowel disease.
    Loftus CG; Egan LJ; Sandborn WJ
    Gastroenterol Clin North Am; 2004 Jun; 33(2):141-69, vii. PubMed ID: 15177532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil for treatment of active inflammatory bowel disease. Clinical and immunological studies.
    Neurath MF; Wanitschke R; Peters M; Hildner K; Tufan R; Meyer zum Büschenfelde KH; Schlaak JF
    Ann N Y Acad Sci; 1998 Nov; 859():315-8. PubMed ID: 9928412
    [No Abstract]   [Full Text] [Related]  

  • 4. Mycophenolate mofetil: new applications for this immunosuppressant.
    Moder KG
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):15-19; quiz 20, 78. PubMed ID: 12546332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety profile of mycophenolate mofetil.
    Basara N; Fauser AA
    Bone Marrow Transplant; 2000 Dec; 26(12):1362-3. PubMed ID: 11223981
    [No Abstract]   [Full Text] [Related]  

  • 6. Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease.
    Fellermann K; Steffen M; Stein J; Raedler A; Hämling J; Ludwig D; Loeschke K; Stange EF
    Aliment Pharmacol Ther; 2000 Feb; 14(2):171-6. PubMed ID: 10651657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil during pregnancy: some words of caution.
    Vento M; Perez Aytes A; Ledo A; Boso V; Carey JC
    Pediatrics; 2008 Jul; 122(1):184-5. PubMed ID: 18596003
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis C and mycophenolate mofetil--a clarification.
    Fasola CG; Klintmalm GB
    Liver Transpl; 2002 Apr; 8(4):411-2; author reply 412-3. PubMed ID: 11965590
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of conventional immunosuppressive drugs in IBD.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Zippi M
    Dig Liver Dis; 2004 Nov; 36(11):766-80. PubMed ID: 15571009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case with Listeria meningitis during administration of mycophenolate mofetil for pemphigus vulgaris.
    Akyol M; Ozçelik S; Engin A; Ozel l ahin G
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1447-8. PubMed ID: 17958877
    [No Abstract]   [Full Text] [Related]  

  • 11. Mycophenolate mofetil and cough.
    Elli A; Aroldi A; Montagnino G; Tarantino A; Ponticelli C
    Transplantation; 1998 Aug; 66(3):409. PubMed ID: 9721817
    [No Abstract]   [Full Text] [Related]  

  • 12. Rationale for trials of long-term mycophenolate mofetil therapy for primary biliary cirrhosis.
    Jones EA
    Hepatology; 2002 Feb; 35(2):258-62. PubMed ID: 11826397
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycophenolate mofetil--a new immunosuppressant for organ transplantation.
    Med Lett Drugs Ther; 1995 Sep; 37(958):84-6. PubMed ID: 7674993
    [No Abstract]   [Full Text] [Related]  

  • 14. Mycophenolate mofetil (RS-61443): preclinical, clinical, and three-year experience in heart transplantation.
    Taylor DO; Ensley RD; Olsen SL; Dunn D; Renlund DG
    J Heart Lung Transplant; 1994; 13(4):571-82. PubMed ID: 7947873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil to the rescue in autoimmune hepatitis: a fresh sprout on the decision tree.
    Czaja AJ
    J Hepatol; 2009 Jul; 51(1):8-10. PubMed ID: 19446910
    [No Abstract]   [Full Text] [Related]  

  • 16. Follow-up on mycophenolate treatment of glomerular disease.
    Briggs WA; Choi MJ; Scheel PJ
    Am J Kidney Dis; 1998 May; 31(5):898-9. PubMed ID: 9590208
    [No Abstract]   [Full Text] [Related]  

  • 17. Mycophenolate mofetil in animal models of autoimmune disease.
    Zandman-Goddard G; Shoenfeld Y
    Lupus; 2005; 14 Suppl 1():s12-6. PubMed ID: 15803926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil is a valid option in patients with inflammatory bowel disease resistant to TNF-α inhibitors and conventional immunosuppressants.
    Macaluso FS; Maida M; Renna S; Orlando E; Affronti M; Sapienza C; Dimarco M; Orlando R; Rizzuto G; Cottone M; Orlando A
    Dig Liver Dis; 2017 Feb; 49(2):157-162. PubMed ID: 27876682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver enzyme abnormalities in patients with atopic dermatitis treated with mycophenolate mofetil.
    Hantash B; Fiorentino D
    Arch Dermatol; 2006 Jan; 142(1):109-10. PubMed ID: 16415398
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience.
    Kirklin JK; Bourge RC; Naftel DC; Morrow WR; Deierhoi MH; Kauffman RS; White-Williams C; Nomberg RI; Holman WL; Smith DC
    J Heart Lung Transplant; 1994; 13(3):444-50. PubMed ID: 8061021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.